BCL2 and glioblastoma: Thus, patients with glioblastoma with a reduced level of Cx43 expression have poor prognosis compared to those who present with histologically and clinically similar disease but whose neoplasm expresses high levels of Cx43 and low levels of bcl-2 [15].